1.Two Cases of Primary Esophageal Diffuse Large B Cell Lymphoma: Therapeutic Considerations and a Literature Review.
Ji Hye KIM ; Yun Hwa JUNG ; In Sook WOO ; Chi Wha HAN ; Min Woo SEO ; Sang Hoon YOO ; So Young HA
Korean Journal of Medicine 2015;88(2):224-230
Primary esophageal lymphoma is very rare, and most reported cases are histologically mucosa-associated lymphoid tissue lymphoma. Therefore, the principle treatment strategy for primary esophageal lymphoma focuses on local treatments, such as endoscopic mucosal resection or radiation therapy, but systemic chemotherapy plays the central role in the treatment of diffuse large B cell lymphoma (DLBCL). Generally, standard treatment for DLBCL is six or three cycles of R-CHOP chemotherapy followed by involved field radiation therapy according to stage. However, the optimal treatment strategy for primary esophageal DLBCL, and the role of additional radiation is not settled, due to a paucity of cases. Moreover, the clinical characteristics related to the etiology and natural course are also unknown. Here, we present two cases of primary esophageal DLBCL with a literature review.
Drug Therapy
;
Esophagus
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Large B-Cell, Diffuse
2.H. pylori Infection and MALT Lymphoma.
Journal of the Korean Gastric Cancer Association 2002;2(2):69-72
No abstract available.
Lymphoma, B-Cell, Marginal Zone*
3.Diagnostic criteria and characteristics of extra-gastric MALT lymphomas.
Korean Journal of Medicine 2000;59(3):251-253
No abstract available.
Lymphoma, B-Cell, Marginal Zone*
5.Classification of Gastrointestinal B-cell Lymphoma and Expression of Cyclin D1, bcl-2, bcl-6, p53 Protein and PCNA.
Ji Han JUNG ; An Hee LEE ; Chang Suk KANG ; Byung Kee KIM
Korean Journal of Pathology 2000;34(6):437-445
Until recently, the gastrointestinal lymphomas were classified according to the criteria developed for the node-based lymphomas. In recent years, the REAL classification provided a new category of MALT lymphoma and Mantle cell lymphoma in B-cell lymphomas. Low-grade MALT lymphomas have been well characterized clinically, histologically, and immunophenotypically. We retrospectively recategorized 41 cases of the primary gastrointestinal B-cell lymphoma and investigated the expression of cyclin D1, bcl-2, bcl-6, p53 protein, and PCNA by immunohistochemical method. The cases were categorized in 5 groups, low grade MALToma, low/high grade MALToma, high grade MALToma, diffuse large cell lymphoma, and mantle cell lymphoma according to the morphological findings. The expression of cyclin D1 protein was restricted to the cases of mantle cell lymphoma. The bcl-2 protein expression was higher in the low grade MALT lymphoma than in the high grade lymphoma (P=0.006). The bcl-2 protein expression was higher in the low grade area than in the high grade area in the low/high grade MALT lymphoma (P=0.005). The bcl-6 and p53 protein expression was higher in the high grade MALT lymphoma than in the low grade lymphoma (P=0.022, P<0.018). However, the bcl-6 protein expression of the tumor cells was higher in high grade area than in low grade area in the low/high grade MALT lymphoma (P=0.004). The degree of the PCNA expression was positively correlated with the grade of the malignant lymphoma (P=0.003). The above results suggest that the cellular proliferation assessed by PCNA index correlates with the histologic grade. And the bcl-2, bcl-6, p53 protein may be effective in the transition from the low grade MALT lymphoma to the high grade lymphoma. Therefore, we can differentiate the low grade lymphoma from the high grade lymphoma by the immunohistochemical staining for cyclin D1, bcl-2, bcl-6, p53 protein and can predict the prognosis of the patients in accordance with the grade of the tumor.
B-Lymphocytes*
;
Cell Proliferation
;
Classification*
;
Cyclin D1*
;
Cyclins*
;
Gastrointestinal Tract
;
Humans
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Large B-Cell, Diffuse
;
Lymphoma, Mantle-Cell
;
Prognosis
;
Proliferating Cell Nuclear Antigen*
;
Retrospective Studies
6.Endoscopic Findings of Gastric Extranodal Marginal Zone B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma.
Clinical Endoscopy 2017;50(1):1-2
No abstract available.
B-Lymphocytes*
;
Lymphoma, B-Cell, Marginal Zone*
7.Treatment and Prognosis of Gastric MALT Lymphoma.
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2011;11(3):165-169
Mucosa-associated lymphoid tissue (MALT) lymphomas represent 7% of all non-Hodgkin's lymphomas and can arise from any extranodal site; however, at least one-third of them present as a primary gastric lymphoma. Eradication of Helicobacter pylori (H. pylori) with antibiotics should be employed as the sole initial treatment of H. pylori-positive gastric MALT lymphoma. H. pylori eradication can induce lymphoma regression and long-term clinical disease control in most patients. In H. pylori-negative cases or patients who fail antibiotics therapy, irradiation and systemic therapies should be applied depending on the stage of disease; surgery has not been shown to achieve superior results in comparison with more conservative approaches in various trials. Lymphoma with diffuse large cell infiltration should be treated according to the recommendations for diffuse large cell lymphoma. H. pylori eradication resulted in complete lymphoma remission in the majority of cases. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of H. pylori had a favorable disease course without oncological treatment. A watch and wait strategy with regular endoscopies and biopsies appears to be safe and may become the approach of choice in this situation. Nevertheless, long-term careful endoscopic and systemic (blood counts and minimal adequate radiological or ultrasound examinations) follow-up once per year is recommended for all patients. This article is a review for the current treatment and prognosis of gastric MALT lymphoma.
Anti-Bacterial Agents
;
Biopsy
;
Helicobacter pylori
;
Humans
;
Lymphoid Tissue
;
Lymphoma
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Large B-Cell, Diffuse
;
Lymphoma, Non-Hodgkin
;
Prognosis
;
Stomach Neoplasms
8.Two Cases of Diffuse Large B-Cell Lymphomas in the Cervical Lymph Nodes in Patients with Low-Grade Gastric Marginal Zone B-Cell Lymphoma (MALT Lymphoma).
Ji Hoon JUNG ; Hwoon Yong JUNG ; Hwan YOON ; Jae Kwang LEE ; Ji Hoon KANG ; Sung Jin JEON ; Young Su PARK ; Jin Ho KIM
Clinical Endoscopy 2013;46(3):288-292
It is well known that gastric mucosa-associated lymphoid tissue (MALT) lymphomas are associated with Helicobacter pylori infection and have a good prognosis. However, although rare, these low-grade lymphomas transform to the high-grade diffuse large B-cell lymphomas (DLBCLs) which are thought to be the important cause of death in patients with MALT lymphoma. We report two cases of DLBCLs in the cervical lymph nodes that occurred 10 years and 1.5 years after diagnosing low-grade gastric MALT lymphomas.
B-Lymphocytes
;
Cause of Death
;
Helicobacter pylori
;
Humans
;
Lymph Nodes
;
Lymphoid Tissue
;
Lymphoma
;
Lymphoma, B-Cell
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Large B-Cell, Diffuse
;
Lymphoma, Non-Hodgkin
;
Prognosis
;
Stomach Neoplasms
9.Rare Case of Primary Gastric Burkitt Lymphoma in a Child.
Soon Chul KIM ; Jung Won HWANG ; Min Kyung LEE ; Pyoung Han HWANG
The Korean Journal of Gastroenterology 2016;68(2):87-92
Primary gastric tumors are very rare in children. Burkitt lymphoma is a common type of non-Hodgkin's lymphoma, and gastric Burkitt lymphoma usually occurs in the aged. When involving the gastrointestinal tract, primary gastric Burkitt lymphoma is very rare in younger childhood. Many gastric lymphomas including mucosa-associated lymphoid tissue lymphoma are associated with Helicobacter pylori infection or acute bleeding symptom. We report a seven-year-old boy who presented with only some vomiting and postprandial pain. His upper gastrointestinal endoscopy and biopsy revealed a large primary Burkitt lymphoma with no acute bleeding and no evidence of H. pylori infection. After chemotherapy, he remains in remission.
Biopsy
;
Burkitt Lymphoma*
;
Child*
;
Drug Therapy
;
Endoscopy, Gastrointestinal
;
Gastrointestinal Tract
;
Helicobacter pylori
;
Hemorrhage
;
Humans
;
Lymphoma
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Non-Hodgkin
;
Male
;
Stomach Neoplasms
;
Vomiting
10.Treatment of Orbital and Ocular Adnexal Malignant Lymphoma.
Jeong Whan LEE ; Wha Sun CHUNG
Journal of the Korean Ophthalmological Society 2003;44(4):800-805
PURPOSE: The aim of this study was to evaluate the clinical features, histologic classification and treatment outcomes of patients with malignant lymphoma of the eye. METHODS: The participants included 22 patients with malignant lymphoma of the orbit and ocular adnexa treated at our hospital between May 1994 and September 2001. The authors retrospectively analyzed the sex, age, location of mass, histopathologic type, stage and results of the treatment. RESULTS: Of the 22 patients, 14 cases were male and 8 were female. The age ranged from 26 to 68 years (mean age 43 years). The most common presenting complaint was slowly growing mass of the eye. Histopathologic studies revealed extranodal marginal zone B-cell lymphoma, MALT type in 20 cases (91%). The stages of lymphomas were included I AE in 14 cases (63%), II AE in 3 cases (14%), III AE in 3 cases (14%) and IV A in 2 cases (9%). Patients received radiotherapy and/or chemotherapy. Twenty out of 22 cases (91%) achieved a complete remission. During the mean follow-up of 26 months, two patients died of progression of the disease; one patient had extranodal marginal zone B-cell lymphoma, MALT type of stage III AE and the other patient had diffuse large cell lymphoma of stage II AE. CONCLUSIONS: Radiotherapy can produce durable remission in the majority of the patients with localized primary orbital lymphoma. Chemotherapy should be performed for the patients with highly malignant lymphomas or lymphomas with systemic manifestations.
Classification
;
Drug Therapy
;
Female
;
Follow-Up Studies
;
Humans
;
Lymphoma*
;
Lymphoma, B-Cell, Marginal Zone
;
Lymphoma, Large B-Cell, Diffuse
;
Male
;
Orbit*
;
Radiotherapy
;
Retrospective Studies